EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Reshaping the tumor immune microenvironment via therapy-induced senescence: senescence-associated secretory phenotype networks and senolytic strategies

Xiaonan Geng, Peide Li, Ke Xu, Shuwen Yang, Xinjun Hu

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-13049-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Xiaonan Geng und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, No. 24 Jinghua Road, Jianxi District, Luoyan…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Senescence-Associated Secretory Phenotype, Cellular Senescence, Neoplasms. Die Arbeit nennt 93 Literaturangaben. Gefördert von: the Key Program of Henan Medical Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anticancer therapy can suppress tumor growth by inducing cell death, but many treatments also impose durable stress programs in malignant and stromal cells. Therapy-induced senescence (TIS) has emerged as a central non-lethal outcome of chemotherapy, radiotherapy and targeted therapy. Senescent cells remain metabolically active and communicate with their surroundings through the senescence-associated secretory phenotype (SASP), a heterogeneous mixture of cytokines, chemokines, growth factors, proteases, extracellular vesicles and immune-modulatory signals. In cancer, this secretory program can support immune surveillance when it is transient and efficiently cleared, yet it can also promote chronic inflammation, immune suppression, stromal remodeling, recurrence and resistance when senescent cells persist. This review summarizes the TIS-SASP-tumor immune microenvironment (TIME) axis, with emphasis on the molecular regulation of SASP, immune-cell-specific remodeling, the biphasic nature of SASP-mediated immunity and the rationale for sequential senogenic-senolytic therapy. Here, "senogenic" refers to interventions that induce cellular senescence, "senolytic" to approaches that selectively eliminate senescent cells, and "senomorphic" to strategies that suppress or remodel harmful senescence-associated phenotypes without necessarily killing senescent cells. We discuss how senolytics, senomorphics and immune checkpoint combinations may convert therapy-induced senescence from a liability into a therapeutically exploitable state. We also highlight the translational barriers that currently limit this strategy, including biomarker specificity, cell-type heterogeneity, treatment timing, safety and the need for spatially resolved monitoring of senescent niches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentSenescence-Associated Secretory PhenotypeCellular SenescenceNeoplasmsSenotherapeuticsHumansAnimals

Stichwörter der Autor:innen

immune checkpoint therapysenescence-associated secretory phenotypesenolyticstherapy-induced senescencetumor immune microenvironment

Substanzen

Senotherapeutics

Autor:innen und Institutionen

  • The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, No. 24 Jinghua Road, Jianxi District, Luoyang, 471000, Henan, China.
  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, No. 24 Jinghua Road, Jianxi District, Luoyang, 471000, Henan, China. hxj5129@163.com.

Förderung

  • the Key Program of Henan Medical Science and Technology

Zitieren

APA

Geng, X., Li, P., Xu, K., Yang, S., & Hu, X. (2026). Reshaping the tumor immune microenvironment via therapy-induced senescence: senescence-associated secretory phenotype networks and senolytic strategies. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-13049-2

Vancouver

Geng X, Li P, Xu K, Yang S, Hu X. Reshaping the tumor immune microenvironment via therapy-induced senescence: senescence-associated secretory phenotype networks and senolytic strategies. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-13049-2

BibTeX
@article{Geng2026,
  author = {Geng, Xiaonan and Li, Peide and Xu, Ke and Yang, Shuwen and Hu, Xinjun},
  title = {Reshaping the tumor immune microenvironment via therapy-induced senescence: senescence-associated secretory phenotype networks and senolytic strategies},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-13049-2}
}
Kostenlos starten →